Sequoia Genetics is a UK-based private limited company founded in 2024. It uses human genetic data to generate translational insights for drug discovery and development, serving pharma, biotech, investors, and academia.

Search Now!
Contact Info
Location Translation and Innovation Hub, 84 Wood Lane, White City, London, W12 0BZ
Follow Us
Contact Info
Location Translation and Innovation Hub, 84 Wood Lane, White City, London, W12 0BZ
Follow Us

Dr Toinét Cronjé

BMBCh MRCP CCT PhD

Scientific Vice President

 

Toinét earned a PhD in Health Science from North-West University, South Africa, focusing on DNA methylation as a mediator between urbanization and cardiometabolic disease. Her pre-doctoral training included a BSc in Health Science (Psychology and Nutrition) and an MSc in Health Science (Nutrition) from the same university. She spent three years as a postdoctoral researcher at the University of Copenhagen, working with proteomic data as disease biomarkers, and later shifted to drug target Mendelian randomization in both academic and industry roles. Alongside her work at Sequoia Genetics, Toinét is a Research Associate at the MRC Biostatistics Unit, University of Cambridge, focusing on drug target Mendelian randomization for psychiatric disorders.

 

At Sequoia Genetics, Toinét specializes in multi-omics data analysis, engaging with clients, developing analytical proposals, integrating data, and delivering insights to stakeholders.